2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year.
What is the pharma forecast for 2024?
The last year ushered in continued pressures for the pharmaceutical industry regarding supply shortages, drug pricing, manufacturing costs, and digitisation. As we enter 2024, the supply chain and industry are looking to take proactive measures to address ongoing challenges. Significant movements in the industry include:
-
Quality Management Maturity: Predictive maintenance will be a key application in addressing pre-emptive quality control measures. The US FDA’s Center for Drug Evaluation has also launched the Quality Management Maturity Program, aimed at encouraging drug manufacturers to implement tangible and cultural mindset changes concerning quality management.
-
Cross-industry collaboration: Whether it’s for meeting sustainability goals, implementing cutting-edge technologies, or accelerating drug approval timelines, collaboration across the pharmaceutical supply and value chain is no longer just a want – it is a need.
-
Generative AI, machine learning, and digital futures: The rapid rise of generative AI models, machine-learning algorithms, and large language models such as Chat GPT will push pharmaceutical operations beyond current capabilities. Data-oriented manufacturing and Big Data Analytics for regulatory compliance will have a significant impact on all pharma players.
Continuing challenges for pharma
Reaching sustainability goals across the pharmaceutical supply chain remains a constant conversation within the industry. In 2024, discussions will focus on the management of difficult-to-quantify scope 3 emissions, new regulations for pharma packaging, and how collaboration is a requirement for the dissemination of information and assessments across the industry.
Excipients are also continuing to see an explosion of interest in 2024. The FDA’s Novel Excipient Pilot Program will start to see the results of their efforts to accelerate approval for excipients. Advancements in personalised medicines, multifunctional ingredients, and advanced therapeutics are also pushing drug manufacturers to look beyond existing excipients that are limiting the kinds of therapeutics available.
Patent expirations up to 2030 will have a significant impact on drug pricing, manufacturing costs, and ultimately whether patients will receive the treatments they need. Focus from the industry on R&D while outsourcing manufacturing activities can have a substantial effect on managing rising costs of drug manufacturing and in turn, the price of drugs. Though the Inflation Reduction Act might penalise drug manufacturers for increasing drug prices, the increase in outsourcing behaviour might cause a shift for companies to expand into the outsourcing manufacturing businesses.
2024 Pharma Trends Outlook: download now!
Keen to know what 2024 will bring for the pharmaceutical industry? Read from our expert contributors and thought-leaders on their predictions for the 12 biggest trends facing the pharmaceutical industry in the next year.
Download our free Trend Report below.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance